My guess is the enrolments are finished and results are being...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 115 Last

Share
Profile

Follow
wop

2,309 Posts.

358

05/03/17

23:08

Post #: 23113925
Share

Originally posted by vwboy ↑

You would think that the three biggest hospitals in the USA are testing the app because it will be a product that they want to use for themselves, not just doing a favour to Resapp to see if it works.

"There are approximately 13.6 million US emergency room visits every year that result in a diagnosis of respiratory disease. 4.6 million of these visits are for children. In the US, 125 million ambulatory care visits are caused by respiratory disease, and ResApp estimates that globally this number is over 700 million.

Used as a clinical aid during emergency room or general clinic consultations, ResApp’s instant, low cost and accurate diagnostic test offers many benefits over the traditional diagnostic pathway. For pneumonia in particular, ResApp’s test costs significantly less than an x-ray and follow-up consultation, and provides accurate results faster which enables physicians to initiate appropriate therapy immediately."

So imo it will be a steady stream of income as soon as FDA approval is given from hospitals and Telehealth providers worldwide.

Cannot see any need for contracts as they would limit usage to a product that will be used all over the world....only other scenario would be a big fat takeover imo.

Expand

My guess is the enrolments are finished and results are being collated now. 1100 enrolments is nothing for 3 massive hospitals of this size. Its not Joondalup. The trails started 9th of December.

I think the results will catch a lot by surprise.

All IMO of coarse.

RAP Price at posting: 32.5¢ Sentiment: Buy Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it